Posted Jun. 28, 2012 at 7:41 a.m.

Premium Lock Cempra strikes drug licensing deal with Scripps Institute

Published: 2012-06-28 07:41:26
Updated: 2012-06-28 07:41:26

Print this blog post
Cempra Cempra

According to Cempra's filing, the drug developer is paying Scripps a one-time license fee of $350,000. The company must also pay Scripps $50,000 annually for the first three years of the agreement and $85,000 from the fourth year onward. If any commercialized products emerge from the agreement, Scripps stands to gain royalties on net sales....

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2013 WRAL Tech Wire. All rights reserved.

Please log in or register to view WRALTechWire Insider content


To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.

 1 Year Membership - 49.99 per year. Includes FREE unlimited access to online content, archives and discounts from Insider Partners. For less than $1 a week receive more than $900 in value.

 Monthly Membership - 4.99 per month. Includes FREE unlimited access every 30 days to online content only.

 Day Pass - 0.99 per day. Includes FREE unlimited access for 24 hours to online content only.

Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Jim Roberts
Entrepreneurship
Scroll